https://crcd2inhibitor.com/map....s-the-co-benefits-re
Initial vancomycin doses remain challenging to determine precisely from these predictive models, but a combination of model-based prediction and therapeutic drug monitoring offers a path toward optimal dose adjustment. A substantial degree of variation is seen in the predictive performance of published PPK models for adult postoperative neurosurgical patients when applied to our patient cohort. Recommending initial vancomycin doses fro
Giống
Bình luận
Đăng lại
